多参数MRI影像组学联合VI-RADS预测膀胱癌病理分级
回顾性纳入185例术前接受mpMRI的膀胱癌患者,从T2WI和DCE最大肿瘤提取影像组学特征,构建影像组学-临床列线图。影像组学签名在训练集和验证集AUC分别为0.961和0.952,联合VI-RADS评分的列线图AUC分别为0.956和0.958,提示可术前预测高级别与低级别膀胱癌。
要点
- 影像组学签名联合VI-RADS评分可提高膀胱癌分级诊断效能。
- 列线图在训练集和验证集均显示良好校准与区分度。
- 决策曲线分析提示列线图具有临床决策效用。
核心结论
- 基于mpMRI的影像组学签名有潜力术前预测膀胱癌病理分级。
- 联合影像组学签名与VI-RADS评分的列线图提高了诊断效能,可能辅助临床决策。
研究设计与样本
- 单中心回顾性研究,纳入2014年8月至2020年4月术前接受mpMRI的185例膀胱癌患者。
- 从动态对比增强和T2WI图像上最大肿瘤提取影像组学特征。
- 采用SMOTE技术平衡低级别组,在训练集构建影像组学签名并在验证集评估。
- 采用单变量和多变量逻辑回归构建列线图。
诊断标准与关键数值
- LASSO模型生成的影像组学签名在SMOTE平衡训练集准确率93.2%、AUC 0.961,验证集准确率89.9%、AUC 0.952。
- 联合影像组学签名和VI-RADS评分的列线图在训练集AUC 0.956、验证集AUC 0.958。
临床应用与阅片要点
- 阅片时可结合VI-RADS评分与影像组学特征评估膀胱癌分级风险。
- 列线图可用于术前辅助区分高级别与低级别膀胱癌,支持治疗决策。
局限性
- 单中心回顾性研究,样本量185例,外部泛化性需进一步验证。
- 采用SMOTE平衡组间比例,可能影响结果稳健性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Pathological grade is important for the treatment selection and outcome prediction in bladder cancer (BCa). We aimed to construct a radiomics-clinical nomogram to preoperatively differentiate high-grade BCa from low-grade BCa.
METHODS: A total of 185 BCa patients who received multiparametric MRI (mpMRI) before surgery between August 2014 and April 2020 were enrolled in our study. Radiomics features were extracted from the largest tumor located on dynamic contrast-enhancement and T2WI images. After feature selection, the synthetic minority over-sampling technique (SMOTE) was performed to balance the minority group (low-grade group). Radiomics signatures were constructed in the training set and assessed in the validation set. Univariable and multivariable logistic regression were applied to build a nomogram.
RESULTS: The radiomics signature generated by the least absolute shrinkage and selection operator model achieved the optimal performance for BCa grading in both the SMOTE-balanced training [accuracy: 93.2%, area under the curve (AUC): 0.961] and validation sets (accuracy: 89.9%, AUC: 0.952). A radiomics-clinical nomogram incorporating the radiomics signature and the Vesical Imaging-Reporting and Data System (VI-RADS) score had novel calibration and discrimination both in the training (AUC: 0.956) and validation sets (AUC: 0.958). Decision curve analysis presented the clinical utility of the nomogram for decision-making.
CONCLUSIONS: The mpMRI-based radiomics signature had the potential to preoperatively predict the pathological grade of BCa. The proposed nomogram combining the radiomics signature with the VI-RADS score improved the diagnostic power, which may aid in clinical decision-making.
引用
- Zheng Z, Xu F, Gu Z, et al. Integrating multiparametric MRI radiomics features and the Vesical Imaging-Reporting and Data System (VI-RADS) for bladder cancer grading. Abdom Radiol (NY). 2021. PMID: 33978825. doi:10.1007/s00261-021-03108-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。